Literature DB >> 313257

Enhancement by interferon of natural killer cell activity in mice.

A Senik, I Gresser, C Maury, M Gidlund, A Orn, H Wigzell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 313257     DOI： 10.1016/0008-8749(79)90039-x

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  19 in total

1.  Effect of recombinant gamma interferon on natural killer cell activity in patients with gastric cancer.

Authors:  Y Kuwahara; K Kusugami; K Morise; K Shimokata
Journal:  Gastroenterol Jpn       Date:  1987-08

2.  Natural cytotoxic (NC) activity: a multi-lineage system regulated by IL-2.

Authors:  E C Lattime; M J Bykowsky; O Stutman
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

3.  Heterogeneous cytotoxic cells that kill NC-sensitive WEHI-164 tumor cells are activated in allogeneic mixed lymphocyte reactions.

Authors:  S Macphail; O Stutman
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

4.  Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.

Authors:  M J Humphries; K M Yamada; K Olden
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  Deficient natural killer cell activity in alcoholic cirrhosis.

Authors:  B Charpentier; D Franco; L Paci; M Charra; B Martin; D Vuitton; D Fries
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

6.  Clinical effect of interferon in malignant brain tumours.

Authors:  M Nagai; T Arai
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

7.  Field production and functional evaluation of chloroplast-derived interferon-alpha2b.

Authors:  Philip A Arlen; Regina Falconer; Sri Cherukumilli; Amy Cole; Alexander M Cole; Karen K Oishi; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2007-05-09       Impact factor: 9.803

8.  Isoprinosine delays the early appearance of autoimmunity in NZB/NZW F1 mice treated with interferon.

Authors:  D Sergiescu; I Cerutti; A Kahan; D Piatier; E Efthymiou
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

9.  Protective effect of low-dose interferon against neonatal murine cytomegalovirus infection.

Authors:  J R Cruz; G J Dammin; J L Waner
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.

Authors:  D Herlyn; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.